Self‐administration of injectable contraceptives: a systematic review

• Published in: BJOG : an international journal of obstetrics and gynaecology Vol. 124; no. 2; pp. 200 - 208
• Main Authors: Kim, CR, Fønhus, MS, Ganatra, B
• Format: Journal Article
• Language: English
• Published: England Wiley Subscription Services, Inc 01.01.2017; John Wiley and Sons Inc
• Subjects: Adult; Birth control; Contraception; Contraception - methods; Contraceptive Agents, Female - administration & dosage; Drug use; Female; Gynecology; Humans; injectable; Injections; Injections - methods; Patient safety; Self Administration - methods; self‐administration; Systematic Review; Systematic Reviews; Young Adult; self-administration; injectable; Contraception
• ISSN: 1470-0328; 1471-0528
• DOI: 10.1111/1471-0528.14248

Background The contraceptive injectable is a safe and effective method that is used worldwide. With the variety of injectable delivery systems, there is potential for administration by the woman herself. Self‐administration of the contraceptive injectable is the subject of this systematic review. Objectives To assess how effective and safe the contraceptive injectable method is when women themselves perform/administer it, compared with when the usual healthcare providers administer it. Search strategy We searched PubMed, Popline, Cochrane, CINAHL, and Embase for articles with subject headings or text words related to ‘self‐administration’ and ‘contraception’. Selection criteria Studies that compared the administration of the contraceptive injectable by the woman herself versus administration by the healthcare provider were included. Outcomes of interest were continuation rates, safety, and the women's overall satisfaction with the contraceptive provider and method. Data collection and analysis We undertook data extraction, descriptive analysis, and assessment of risk of bias. Main results Three studies met the inclusion criteria. The best available evidence shows that there may be little or no difference in continuation rates when women self‐administer contraceptive injections (326 per 1000 women; 95% CI 192–554 per 1000 women) compared with administration by healthcare providers (304 per 1000 women). Safety was not estimable as no serious adverse events were reported in any of the studies. With regards to overall satisfaction towards the provider and the method, the effect of the intervention was uncertain. Authors’ conclusions Findings suggest that with appropriate information and training the provision of contraceptive injectables for the woman to self‐administer at home can be an option in some contexts. Tweetable This review assessed the continuation rates and safety of self‐administration of the contraceptive injection. Tweetable This review assessed the continuation rates and safety of self‐administration of the contraceptive injection.